Abstract
This study provides evidence for the presence of opioid-receptors in the retina, optic nerve, and optic nerve head astrocytes. These receptors were measured by more than one technique including Western blotting, immunohistochemistry, and functional assays such as scotopic electroretinogram (ERG) and Pattern ERG. I also have provided evidence in recently published work from my laboratory that opioid receptors, more specifically δ-opioid receptors, play crucial roles in retina neuroprotection against ischemic and glaucomatous injuries. This chapter provides detailed procedures to measure opioid receptor activation and their roles in retina neuroprotection using functional assays such as scotopic ERG and pattern ERG.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chen Y, Mestek A, Liu J et al (1993) Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 44:8–12
Beckett AH, Casy AF (1954) Synthetic analgesics: stereochemical considerations. J Pharm Pharmacol 6:986–1001
Portoghese PS (1965) A new concept on the mode of interaction of narcotic analgesics with receptors. J Med Chem 8:609–616
Terenius L (1973) Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Pharmacol Toxicol 32:317–320
Simon EJ, Hiller JM, Edelman I (1973) Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. Proc Natl Acad Sci U S A 70:1947–1949
Fichna J, Gach K, Piestrzeniewicz M et al (2006) Functional characterization of opioid receptor ligands by aequorin luminescence-based calcium assay. J Pharmacol Exp Ther 317:1150–1154
Kieffer BL, Befort K, Gaveriaux-Ruff C et al (1992) The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A 89:12048–12052
Evans CJ, Keith DE Jr, Morrison H et al (1992) Cloning of a delta opioid receptor by functional expression. Science 258:1952–1955
Fukuda K, Kato S, Mori K (1993) Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes. FEBS Lett 327:311–314
Knapp RJ, Malatynska E, Fang L et al (1994) Identification of a human delta opioid receptor: cloning and expression. Life Sci 54: PL463–PL469
Zhu Y, Hsu MS, Pintar JE (1998) Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J Neurosci 18:2538–2549
Wittert G, Hope P, Pyle D (1996) Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Commun 218: 877–881
Meng F, Xie GX, Thompson RC (1993) Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A 90:9954–9958
Yasuda K, Raynor K, Kong H et al (1993) Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc Natl Acad Sci U S A 90:6736–6740
Simonin F, Gaveriaux-Ruff C, Befort K et al (1995) kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. Proc Natl Acad Sci U S A 92: 7006–7010
Xie GX, Meng F, Mansour A et al (1994) Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor. Proc Natl Acad Sci U S A 91:3779–3783
Min BH, Augustin LB, Felsheim RF et al (1994) Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc Natl Acad Sci U S A 91:9081–9085
Wang JB, Johnson PS, Persico AM et al (1994) Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett 338:217–222
Pampusch MS, Osinski MA, Brown DR et al (1998) The porcine mu opioid receptor: molecular cloning and mRNA distribution in lymphoid tissues. J Neuroimmunol 90: 192–198
Onoprishvili I, Andria ML, Vilim FS et al (1999) The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells. Brain Res Mol Brain Res 73:129–137
Barrallo A, Gonzalez-Sarmiento R, Alvar F et al (2000) ZFOR2, a new opioid receptor-like gene from the teleost zebrafish (Danio rerio). Brain Res Mol Brain Res 84:1–6
Husain S, Potter DE, Crosson CE (2009) Opioid receptor-activation: retina protected from ischemic injury. Invest Ophthalmol Vis Sci 50:3853–3859
Husain S, Abdul Y, Crosson CE (2012) Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model. Invest Ophthalmol Vis Sci 53: 4289–4298
Abdul Y, Akhter N, Husain S (2013) Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model. Invest Ophthalmol Vis Sci 54:1816–1828
Parolaro D, Patrini G, Giagnoni G et al (1990) Pertussis toxin inhibits morphine analgesia and prevents opiate dependence. Pharmacol Biochem Behav 35:137–141
Gomes BA, Shen J, Stafford K et al (2002) Mu-opioid receptor down-regulation and tolerance are not equally dependent upon G-protein signaling. Pharmacol Biochem Behav 72: 273–278
Drago F, Panissidi G, Bellomio F et al (1985) Effects of opiates and opioids on intraocular pressure of rabbits and humans. Clin Exp Pharmacol Physiol 12:107–113
Drago F, Gorgone G, Spina F et al (1980) Opiate receptors in the rabbit iris. Naunyn Schmiedebergs Arch Pharmacol 315:1–4
Selbach JM, Buschnack SH, Steuhl KP et al (2005) Substance P and opioid peptidergic innervation of the anterior eye segment of the rat: an immunohistochemical study. J Anat 206:237–242
Stone RA, Kuwayama Y, Laties AM (1987) Regulatory peptides in the eye. Experientia 43:791–800
Murray RB, Adler MW, Korczyn AD (1983) The pupillary effects of opioids. Life Sci 33: 495–509
Drago F, Aguglia E, Dal Bello A et al (1985) Ocular instillation of naloxone increases intraocular pressure in morphine-addicted patients: a possible test for detecting misuse of morphine. Experientia 41:266–267
Fanciullacci M, Boccuni M, Pietrini U et al (1980) The naloxone conjunctival test in morphine addiction. Eur J Pharmacol 61: 319–320
Russell KR, Wang DR, Potter DE (2000) Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist. Exp Eye Res 70:675–682
Wang D, Potter DE (1996) Ocular action of an opioid peptide, DPDPE. J Ocul Pharmacol Ther 12:131–139
Moore TT, Potter DE (2001) Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation. Exp Eye Res 73:167–178
Chu TC, Potter DE (2002) Ocular hypotension induced by electroacupuncture. J Ocul Pharmacol Ther 18:293–305
Kurusu M, Watanabe K, Nakazawa T et al (2005) Acupuncture for patients with glaucoma. Explore 1:372–376
Husain S, Abdul Y, Potter DE (2012) Non-analgesic effects of opioids: neuroprotection in the retina. Curr Pharm Des 18:6101–6108
Husain S, Potter DE (2008) The opioidergic system: potential roles and therapeutic indications in the eye. J Ocul Pharmacol Ther 24: 117–140
Porciatti V (2007) The mouse pattern electroretinogram. Doc Ophthalmol 115:145–153
Wanger P, Persson HE (1983) Pattern-reversal electroretinograms in unilateral glaucoma. Invest Ophthalmol Vis Sci 24:749–753
Acknowledgements
Supported in part by NIH/NEI grant EY019081 and an unrestricted grant to MUSC-SEI from Research to Prevent Blindness, New York, NY.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Husain, S. (2015). Opioid Receptors: Methods for Detection and Their Modes of Actions in the Eye. In: Spampinato, S. (eds) Opioid Receptors. Methods in Molecular Biology, vol 1230. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1708-2_20
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1708-2_20
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1707-5
Online ISBN: 978-1-4939-1708-2
eBook Packages: Springer Protocols